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Abstract
Background: A 37 year-old man presented to the emergency department complaining of six hour
diffuse abdominal pain accompanied by persistent vomiting.
Case report: The patient had a heavy meal a few hours before. There were no signs of peritonitis.
Routine laboratory examinations revealed leukocytosis, hyperglycemia and hyperamylasemia
(serum amylase: 380 mg/dl, urinary amylase: 1150 mg/dl).
Conclusion: The lipid profile revealed an impressive elevation of triglycerides (4800 mg/dl) and
cholesterol (1009 mg/dl) levels. The serum was extremely lipemic. The abdomen computed
tomography confirmed the diagnosis of pancreatitis.
Document
A 37 year-old man presented to the emergency depart-
ment complaining of six hour diffuse abdominal pain
accompanied by persistent vomiting. The patient had a
heavy meal a few hours before. His past personal history
was positive for heavy alcohol consumption, but there
was no known history of diabetes mellitus. The patient
reported that his father suffered from hypercholestero-
lemia controlled by a low dose of statin. The patient's
physical examination revealed normal bowel sounds and
a mild diffuse abdominal tenderness. There were no signs
of peritonitis. The rest of the clinical examination was
without abnormal findings. His vital signs were: Blood
Pressure: 160/90 mmHg, Heart Rate: 86 bpm. Respiratory
Rate: 26 breaths/min, Rectal Temperature: 37,1°C Pulse
Oximetry: 95% (on air). Routine laboratory examinations
revealed leukocytosis (WBC: 13,3 K/μl), hyperglycemia
(378 mg/dl) and hyperamylasemia (serum amylase: 380
mg/dl, urinary amylase: 1150 mg/dl). BMI was 29 kgr/m2.
The lipid profile revealed an impressive elevation of trig-
lycerides (4800 mg/dl) and cholesterol (1009 mg/dl) lev-
els. The serum was extremely lipemic (Figure 1). The
abdomen computed tomography confirmed the diagnosis
of pancreatitis. The patient was admitted for further eval-
uation and treatment. He was managed conservatively
with lipid-lowering medications (atorvastatin, fenofi-
brate), hydration and dietary restriction. The patient was
treated with rapid acting insulin for 2 days during admis-
sion. Moreover, he underwent two sessions of plas-
mapheresis, in order to achieve quick and acute
improvement, but was never admitted to the ICU. His
clinical condition improved significantly and the patient
was discharged in good health five days later, with a trig-
lyceride level of 420 mg/dl. Alcohol consumption was the
secondary releasing factor of this episode of acute pancre-
atitis.
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Hypertriglyceridemia is a relatively uncommon cause of
pancreatitis [1]. Pancreatitis secondary to hypertriglyceri-
demia typically presents as an episode of acute pancreati-
tis (AP) or recurrent pancreatitis and rarely as chronic
pancreatitis [1,2]. An important and usually identifiable
risk factor is a serum triglycerides level of 1000-2000 mg/
dl in a patient with an already known type I, IV or V hyper-
lipidemia (Fredrickson's classification). The typical clini-
cal profile is a patient presenting with a preexisting lipid
abnormality in combination with a secondary co-releas-
ing factor, such as poorly controlled diabetes mellitus,
medications related to induction of AP or alcohol con-
sumption. In addition to the usual findings in AP, in
Hyperlipidemic Pancreatitis (HLP), the serum pancreatic
enzymes may be normal or slightly elevated [3], even in
the presence of severe AP that has been confirmed by
imaging techniques [2,4]. The diagnostic hallmark con-
sists of a mildly elevated amylase with interestingly low
urine amylase levels along with the presence of lipemic
serum in a patient with a family history of disturbed lipid
profile [1]. As far as it concerns the clinical course of HLP,
it does resemble to that of AP derived from other causes,
with similar complications but not in a higher rate than in
other types of AP. Routine management should not differ
much, aiming at a reduction of triglyceride levels to less
than 1000 mg/dl, through dietary restriction of fat and
lipid-lowering medications (mainly fibric acid deriva-
tives). Such a reduction has been proved to prevent from
recurrent episodes of AP, whereas there are anecdotal
reports of other therapies, such as plasmapheresis.
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